Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Glucose Homeostasis in Prediabetes
NCT01409993Phase 4Terminated
- Sponsor
- Vanderbilt University
- Start
- Aug 2011
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ASP-001 in impaired glucose tolerance (IGT), prediabetes and metabolic syndrome (4 arms), sponsored by Vanderbilt University. Primary endpoints: Insulin Secretion at 3 months, Index of Tissue Sensitivity to Insulin at 3 months and 1 more. Started Aug 2011; status: terminated.
02
Drugs
ASP-001
03
Conditions
impaired glucose tolerance (IGT)prediabetesmetabolic syndrome
Beyond the preview
Go deeper on NCT01409993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01409993.